Common clinical categories include: Hormonal peptides e.g., semaglutide (GLP-1 agonist) Growth hormone secretagogues e.g., CJC-1295, Ipamorelin Regenerative peptides e.g., BPC-157, thymosin beta-4 Cosmetic peptides e.g., GHK-Cu for collagen and wound healing Despite overlapping with legitimate FDA-approved drugs, most peptides marketed for wellness use are unapproved and compounded , raising both regulatory and ethical questions
Never stop or change a prescription medicine without talking to your doctor first
The books are the same mission, smaller scale: build the map where none exists
Choosing the right reconstitution volume for your protocol The charts give you options
Can genetic testing help me understand my pain tolerance or medication sensitivity
However, the FDA label explicitly states that "it is unknown whether GLP-1 receptor agonists cause thyroid C-cell tumors, including medullary thyroid carcinoma (MTC), in humans, as the human relevance of GLP-1 receptor agonist-induced rodent thyroid C-cell tumors has not been determined." The rodent thyroid has substantially more C-cells than the human thyroid, and rodents may be more susceptible to this effect
&srotate=0)
